YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Ono Pharmaceutical Co. (OPHLF) shares ended the last trading session 13.9% higher at $16.11. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.8…
Earnings Call Insights: NRx Pharmaceuticals (NRXP) Q2 2026 MANAGEMENT VIEW * “The second quarter of 2026, was a major inflection point for our company across multiple key objectives” (Co-Founder, Chairman & CEO Jonathan Javitt), citing pro…
NRx Pharmaceuticals, Inc. (NRXP) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.98 per share a year ago. These figures are adjusted for non-recurring…
NRx Pharmaceuticals, Inc. (NRXP) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.98 per share a year ago. These figures are adjusted for non-recurring…
MIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and Q&A session on Mo…
[US Food and Drug Administration (FDA)] Shares of NRx Pharmaceuticals (NRXP [https://seekingalpha.com/symbol/NRXP]) rose on Friday after the company announced that the FDA didn't identify any major deficiencies as part of an initial review…
(RTTNews) - NRx Pharmaceuticals, Inc. (NRXP) reported that the U.S. FDA has completed its first-cycle review of the company's Abbreviated New Drug Application (ANDA) for preservative-free ketamine, finding no major deficiencies in the drug…
FDA identified no major deficiencies related to the ketamine drug product, ingredients, proposed labeling, CMC, or other drug-related review matters.Remaining item relates to manufacturer certification for a luer lock vial already used in…
We recently compiled a list of the 7 Best Psychedelic Stocks to Buy According to Analysts. NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) is one of the best psychedelic stocks on our list. TheFly reported on June 25 that NRXP issued a statement r…
Incannex Healthcare Inc. (NASDAQ:IXHL) is one of the best strong buy penny stocks to invest in now. Incannex Healthcare Inc. (NASDAQ:IXHL) announced on June 25 the granting of a key patent by the United States Patent and Trademark Office (…
(RTTNews) - July is here, and the FDA is set to announce decisions on therapies for conditions ranging from breast cancer and IgA nephropathy to multiple myeloma, ADHD, and wet AMD. Before turning our attention to the key FDA decisions exp…
(RTTNews) - NRx Pharmaceuticals, Inc. (NRXP), a clinical-stage biopharmaceutical company, announced that its subsidiary HOPE Therapeutics, Inc. has initiated treatment of patients with major depressive disorder using FDA-cleared Zeta TMS N…
Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index adding 0.8% a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
(RTTNews) - NRx Pharmaceuticals, Inc. (NRXP), Monday announced that the Food and Drug Administration has approved an Intermediate Population Expanded Access Protocol for the use of NRX-101, a fixed dose combination of D-cycloserine and lur…
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), featuring a year-to-date gain of 52.77% and upside potential of 987.00%, secures a spot on our list of hot biotech stocks under $5 to buy.NRx Pharmaceuticals (NRXP) Closes Underwritten Public Offeri…
WILMINGTON, Del., June 04, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced unde…
(RTTNews) - Pre-market trading is offering an early glimpse into biotech stocks likely to attract investor attention this Wednesday. Significant price moves ahead of the opening bell are being driven by clinical trial updates, public and p…
(RTTNews) - NRx Pharmaceuticals (NRXP), a clinical-stage biopharmaceutical company, on Tuesday announced a proposed underwritten public offering. Following the announcement, shares dipped by 22% in the overnight trade on Wednesday. The com…
* NRx Pharmaceuticals (NRXP [https://seekingalpha.com/symbol/NRXP]) said [https://seekingalpha.com/pr/20537823-nrx-pharmaceuticals-inc-announces-proposed-public-offering-of-common-stock] Tuesday it plans to launch an underwritten public of…
EMOCARE is a smartphone-based passive monitoring tool that generates a continuous, real-time measure of depression from patient voice, facial expression, motion, and screen behavior, and is the first passive monitoring tool for psychiatric…
With an upside potential of 1194.87%, NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) is among the 7 Best Rated Penny Stocks to Buy According to Wall Street Analysts. On May 13, Lucid Capital initiated coverage of NRx Pharmaceuticals, Inc. (NASDAQ…
Key Points Schrödinger combines AI-driven drug discovery with a real software revenue business. Sarepta focuses on gene therapy and is delivering solid sales despite ongoing regulatory concerns. NRX awaits upcoming FDA decisions and depres…
Biotech investors are finally getting something they haven't seen in years: a friendlier macro environment. Interest rates appear to be stabilizing, FDA activity is picking up again, and large pharmaceutical companies are sitting on billio…
Key Points Interested in NRx Pharmaceuticals, Inc.? Here are five stocks we like better. KETAFREE moved closer to a potential summer 2026 approval after the FDA issued mostly minor review comments, and NRx said it has already begun commerc…
Major earnings expected before the bell on Monday include: * Baidu (BIDU [https://seekingalpha.com/symbol/BIDU]) * iQIYI (IQ [https://seekingalpha.com/symbol/IQ]) * Ryanair Holdings plc (RYAAY [https://seekingalpha.com/symbol/RYAAY]) * Niu…
Quick Read: The April inflation spike hit stocks hard, as only the Dow Jones Industrial Average finished Tuesday modestly higher. With inflation at its highest level in over 3 years, it’s unlikely the Federal Reserve will cut interest rate…
Special continuing M&A Segment with Senior M&A Partner at Sullivan & Cromwell LLP, Frank Aquila NEW YORK CITY, NY / ACCESS Newswire / April 11, 2026 / New to The Street announces its latest nationally broadcast episode airing tonight at 6:…
Key Takeaways; Cannabis Sector Tilray Brands Global Push is Paying Off as International Cannabis Growth Drove Record Q3 Revenue Charlotte’s Web Strengthened Balance Sheet as British American Tobacco Deepened Stake Amid Strategic Growth Pus…
NRx Pharmaceuticals, Inc (NASDAQ:NRXP) is among the best psychedelic stocks to buy in 2026. NRx Pharmaceuticals, Inc (NASDAQ:NRXP)’s drug candidates NRX-101 and NRX-100 are being developed as a treatment for suicidal depression and other b…
NRx Pharmaceuticals logo 5 Biotech stocks tapping into unmet mental health treatment needs NRx Pharmaceuticals (NASDAQ:NRXP) executives used the company’s fourth-quarter 2025 results call to outline what they described as a “pivotal and tr…
NRx Pharmaceuticals logo Key Points 2025 described as "extraordinarily pivotal": NRx said it is "in the FDA" with at least one drug it hopes could be approved this year and is operating revenue-generating clinics treating patients daily. S…
Major earnings expected before the bell on Tuesday include: * Xiaomi Corporation (XIACF [https://seekingalpha.com/symbol/XIACF]) * Vertical Aerospace Ltd. (EVTL [https://seekingalpha.com/symbol/EVTL]) * Concentrix Corporation (CNXC [https:…
Featured Companies Include FreeCast (NASDAQ:CAST), KLED.ai, Lantern Pharma (NASDAQ:LTRN), and BlackBarn Restaurant NEW YORK CITY, NY / ACCESS Newswire / March 21, 2026 / New to The Street, one of the longest-running U.S. and international…
The bipolar depression market is anticipated to increase during the forecast period (2026–2036), owing to the rise in the launch of emerging therapies such as Azetukalner (Xenon Pharmaceuticals), Elunetirom (ABX-002) (Autobahn Therapeutics…
Prof. Brown is a pioneer in Transcranial Magnetic Stimulation (TMS) and serves as current President of the Clinical TMS Society and Editor-in-Chief of the Transcranial Magnetic Stimulation journal.Extensive publication history in the scien…
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Alpha Tau Medical Ltd. DRTS is a clinical-stage oncology therapeutics company. The Zacks Consensus Estimate for its current year earnings has been revised 2% downwa…